脑梗死的溶栓治疗

　　3　Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology,1992,42:976-982.

　　4　Levy DE, Brott TG, Haley EC Jr, et al. Factors related to intracranial hematoma formation in patients receiving tissue plasminogen activator for acute ischemic stroke. Stroke,1994,25,291-297.

　　5　Wardlaw JM, Warlow CP. Thrombolysis in acute ischemic stroke: dose it work? Stroke,1992,23:1826-1839.

　　6　von Kummer R,Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke,1992, 23:646-652.

　　7　贺茂林, 陈清棠. 急性脑梗塞尿激酶静脉溶栓治疗的初步临床观察. 96神经内科学术年会论文汇编, 1996.3-4.

　　8　Brott TG, Haley EC Jr, Levy DE, et al. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke, 1992,23:632-640.

　　9　Haley EC Jr, Levy DE, Brott TG, et al. Urgent therapy for stroke. Part Ⅱ. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke,1992,23:641-645.

　　10　Haley EC Jr, Brott TG,Sheppard GL, et al. Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group. Stroke,1993,24:1000-1004.

　　11　Marshall RS, Mohr JP. Current management of ischaemic stroke. J Neurol Neurosurg Psychiatry, 1993,56:6-16.

　　12　Levine SR, Brott TG. Thrombolytic therapy in cerebrovascular disorders. Prog Cardiovasc Dis, 1992,34:235-262.

　　13　Sloan MA, Price TR, Petito CK, et al. Clinical features and

　　14　Ueda T, Hatakeyama T, Kumon Y, et al. Evaluation of

上一页  [1] [2] [3] [4] 下一页